All Blogs

Oct 31, 2022

Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market


Oct 28, 2022

HUMIRA Biosimilars in the US: The Talk of the Psoriatic Arthritis Treatment Market


Oct 27, 2022

FDA Approval to DePuy TELIGEN System; FDA Breakthrough Device Designation for the EndoStim System; GE and Accuray Announces Collaboration; Mentice and Acandis Announces a Three-Year Agreement; Indigo Diabetes Enrolled First Participant in the Shine Clinical Trial; FDA IDE Approval to MedAlliance’s SELUTION SLR


Oct 26, 2022

Navigating the Emerging Trends and Technologies in the Spinal Cord Injury Rehabilitation Segment


Oct 25, 2022

Sumitomo to Purchase Myovant; AstraZeneca’s Tremelimumab Plus Imfinzi Approved in the US; AbbVie Acquires DJS Antibodies; Roche and Hookipa Pharma Signs USD 25 Million Deal; FDA Accepts BMS’s New Drug Application for CAMZYOS; Jazz and Zymeworks Sign Exclusive Licencing Agreement


Oct 24, 2022

Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients


Oct 21, 2022

Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market


Oct 20, 2022

Biosense Webster’s HELIOSTAR Radiofrequency Balloon Ablation Catheter; Philips’s ClarifEye Augmented Reality Surgical Navigation Solution; NeuroLogica’s Elite Mobile Computed Tomography Devices; Medtronic’s Natural Conduction System for Heart; Pfizer & BioNTech’s Omicron BA.4/BA.5-Adapted Bivalent Booster Trial; Castle Biosciences’s TissueCypher® Barrett’s Esophagus Test


Oct 19, 2022

Evaluating the Key Trends and Technologies Shaping the Future of Dentistry


Oct 18, 2022

CHMP Reviews Takeda’s Qdenga; FDA Sets Date for Gilead’ Trodelvy Review; Odyssey’s Announces $ 168 Million Series B Financing; Tavros and Vividion Signs Agreement; Pharming Submits Leniolisib for Approval in the EU; FDA Fast Track Designation to Mereo’s Alvelestat